The transfusion chain begins with donor considerations (whether their donation is safe for them to do and whether the donation is safe for any patient to receive). Once blood is collected, the safety of the blood product is the main focus of activity (Transfusion transmitted testing, compatibility testing, necessary modifications such as irradiation or leukocyte reduction). The endpoint of the transfusion process involves recipient considerations (proper identification of the unit and the patient, appropriateness of blood as the best treatment modality, administration of the unit, evaluation of the recipient) and safe disposal of unused or empty blood bags as per BMW policy.

With a mission of "To provide best in class safe, secure and cost-effective, hassle-free supply of blood products and perform a critical role in clinical services to meet the needs of the healthcare community, patients and our donors through advanced transfusion medicine" Blood Center, Mahatma Gandhi Medical College & Hospital (MGMCH) is providing world-class transfusion services.

First NABH accredited blood center and is ranked one by National Blood Transfusion Council among all the medical college based blood centers in the State of Rajasthan. It has the first state of art Transplant Immunology lab (NABL accredited) with the facility of Luminex, Flowcytometer, Next Generation Sequencing (NGS), and has received appreciation for ABOi Renal transplant and for cadaveric transplant HLA testing in the State of Rajasthan.

Blood center has recent and advanced facilities including Hematopoietic stem cell harvesting, Granulocyte Concentrate, Lymphocyte Collection, Leukodepleted blood products, blood irradiation, Single donor platelets, COVID-19 Convalescent Plasma, NAT tested blood products, component modification for Intrauterine transfusion, Thalassemia screening, Immunophenotyping and molecular testing for leukemia, the workup for autoimmune hemolytic anemia, red cell antibody screening of all the donors and recipient and therapeutic procedures ie therapeutic plasma exchange in life-threatening cases of Myasthenia Gravis, G B Syndrome, etc and double cascade plasmapheresis in ABO-incompatible renal transplant. We are actively participating in the Haemovigilance Program of India (HvPI), Ministry of Health and Family Welfare, GoI with a dedicated hemovigilance Nurse.